Human IFN alpha/beta R2 PharmaGenie ELISA Kit (SBRS0695)

The Assay Genie PharmaGenie ELISA platform delivers quantitative measurement of human interferon alpha/beta receptor subunit 2 (IFNAR2), a transmembrane signaling component of the type I interferon pathway that binds IFN-α and IFN-β ligands. Researchers use this kit to investigate IFNAR2 expression in cell culture supernatant, plasma, and serum specimens, supporting studies in cytokine signaling, antiviral immunity, autoimmune disease biology, and the development of interferon-based therapeutics. Each kit provides reagents sufficient for 96 assays in a microplate format with a colorimetric readout captured on standard ELISA plate readers. The assay is validated for human IFNAR2 reactivity, enabling reproducible quantification of receptor levels in translational research workflows.